These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 25557723)
1. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma. Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
3. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
4. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma. Zhang Z; Meng G; Wang L; Ma Y; Guan Z Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma. Zhang HX; Jiang SS; Zhang XF; Zhou ZQ; Pan QZ; Chen CL; Zhao JJ; Tang Y; Xia JC; Weng DS Oncotarget; 2015 Oct; 6(33):34800-17. PubMed ID: 26430962 [TBL] [Abstract][Full Text] [Related]
6. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. Zhou T; Gao Y World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762 [TBL] [Abstract][Full Text] [Related]
8. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma. Liu T; Chen J; Xiao S; Lei X Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039 [TBL] [Abstract][Full Text] [Related]
9. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma. Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922 [TBL] [Abstract][Full Text] [Related]
10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
11. The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular Carcinoma. Wang J; Gong L; Zhu SJ; Zhu Q; Yao L; Han XJ; Zhang JR; Li YH; Zhang W PLoS One; 2015; 10(9):e0137579. PubMed ID: 26356417 [TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
13. Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Shao X; Zhu J; Shi Y; Fang H; Chen J; Zhang Y; Wang J; Jian H; Lan S; Jiang F; Zhong F; Zhang Y; Cao C Aging (Albany NY); 2022 Dec; 14(23):9632-9646. PubMed ID: 36470669 [TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
15. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
16. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. Wang W; Jia WD; Hu B; Pan YY Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
18. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
20. Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. Liu J; Wang K; Yan Z; Xia Y; Li J; Shi L; Zou Q; Wan X; Jiao B; Wang H; Wu M; Zhang Y; Shen F PLoS One; 2016; 11(5):e0154767. PubMed ID: 27182739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]